Bright Health Group (BHG) reported Q4 EPS of ($0.34), $0.15 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $551.4 billion, versus $380.2 billion reported last year.
GUIDANCE:
Bright Health Group sees FY2023 revenue of $2.9-3.1 billion, versus the consensus of $3.2 billion.
- On a segment basis, Bright HealthCare Revenue is expected to be greater than $1.8 billion, while Consumer Care Revenue is expected to be between $1.1 billion and $1.3 billion.
- Enterprise Adjusted Operating Cost Ratio is expected to be between 13% and 14%†
- Bright Health Group expects to be Adjusted EBITDA profitable in 2023†